Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics, focusing on cannabis-based products. The company specializes in producing cannabis for researchers across the United States and conducting USDA-compliant THC testing of hemp. With full DEA compliance for botanically derived cannabinoids, BRC aims to address unmet medical needs using innovative cannabinoid therapeutics.
BRC has developed proprietary poly-cannabinoids in titratable formulations, demonstrating their commitment to advancing cannabinoid research. The company's mission centers on creating safe and effective cannabinoid-based treatments, positioning itself at the forefront of this emerging field in pharmaceutical development. BRC's work contributes to the growing body of knowledge surrounding the potential medical applications of cannabis-derived compounds.